| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
xanthine dehydrogenase | 0.529 | 0.846 | 2.6E-22 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1988 | 1988 | ||||||||
|
interleukin 1 alpha | 0.333 | 0.962 | 1.6E-04 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1995 | 1995 | ||||||||
|
platelet and endothelial cell adhesion molecule 1 | 0.426 | 0.846 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1996 | 1996 | |||||||||
|
amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase | 0.644 | 0.615 | 2.8E-27 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
ankyrin 2 | 0.626 | 0.538 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
ankyrin 1 | 0.540 | 0.885 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
solute carrier family 2 member 4 | 0.528 | 0.769 | 4.7E-05 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
prostaglandin E receptor 3 | 0.601 | 0.731 | 0.37 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
myoglobin | 0.556 | 0.731 | 3.1E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
complement C3 | 0.445 | 0.885 | 0.90 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
C-X-C motif chemokine ligand 1 | 0.449 | 0.923 | 0.12 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
C-X-C motif chemokine ligand 6 | 0.582 | 0.692 | 2.7E-09 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
C-X-C motif chemokine ligand 2 | 0.513 | 0.885 | 3.6E-07 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
lumican | 0.543 | 0.731 | 7.7E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
activating transcription factor 3 | 0.494 | 0.885 | 8.9E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
annexin A1 | 0.442 | 0.885 | 1.2E-07 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
opioid receptor delta 1 | 0.604 | 0.731 | 3.3E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
oxidized low density lipoprotein receptor 1 | 0.544 | 0.769 | 7.2E-03 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
calpastatin | 0.541 | 0.846 | 4.1E-12 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
potassium inwardly rectifying channel subfamily J member 8 | 0.619 | 0.538 | 0.38 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2000 | 2002 | ||||||||
|
protein disulfide isomerase family A member 3 | 0.566 | 0.769 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
BTG anti-proliferation factor 2 | 0.587 | 0.538 | 1.9E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
angiopoietin 2 | 0.410 | 0.846 | 0.83 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 |